SCHEMBL2656937

SCHEMBL2656937

COCC(C)Oc1nc(Oc2ccc(S(C)(=O)=O)cc2)nc(C(=O)O)n1

nearest known ligand 0.49

Predicted protein targets (top 5)

geneUniProtsupporting neighboursconfidence
GCK P35557 18/20 0.49
KCNH2 Q12809 3/20 0.47
CDK1 P06493 1/20 0.40
CDK2 P24941 1/20 0.40
KDR P35968 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2656881 0.83 GCK (0.51) GCKKCNH2CDK1CDK2KDR
SCHEMBL945414 0.82 GCK (0.49) GCKKCNH2
SCHEMBL2657829 0.82 GCK (0.49) GCKKCNH2
SCHEMBL2658299 0.82 GCK (0.41) GCKKCNH2CDK1CDK2KDR
SCHEMBL944854 0.80 GCK (0.54) GCKKCNH2
SCHEMBL943469 0.76 GCK (0.54) GCKKCNH2
SCHEMBL1107440 0.75 GCK (0.71) GCKKCNH2
SCHEMBL1528218 0.75 GCK (0.71) GCKKCNH2
SCHEMBL2669558 0.74 GCK (0.52) GCKKCNH2
SCHEMBL2659560 0.72 GCK (0.45) GCKKCNH2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2245025-A1 CARBOXAMIDE-HETEROARYL DERIVATIVES FOR THE TREATMENT OF DIABETES Merck Patent GmbH (DE) 2010-11-03 EP claimed
WO-2009106209-A1 CARBOXAMIDE-HETEROARYL DERIVATIVES FOR THE TREATMENT OF DIABETES MERCK PATENT GMBH (DE) 2009-09-03 WO claimed
EP-2245025-A1 CARBOXAMIDE-HETEROARYL DERIVATIVES FOR THE TREATMENT OF DIABETES Merck Patent GmbH (DE) 2010-11-03 EP disclosed
WO-2009106209-A1 CARBOXAMIDE-HETEROARYL DERIVATIVES FOR THE TREATMENT OF DIABETES MERCK PATENT GMBH (DE) 2009-09-03 WO disclosed